Malaria Vaccine Clinical Trials
Sanaria's innovative vaccine candidates are being evaluated in clinical studies throughout Africa, where they aim to help the people that need them the most.
CLINICAL TRIAL LOCATIONS
Clinical trials of PfSPZ-based products have been conducted and are active in the United States, Europe, and Africa.
0
SUBJECTS INJECTED
Our subjects have ranged from infants to the elderly.
0
PfSPZ INJECTED
To date we have safely administered over 5.6 billion PfSPZ to research subjects with no significant differences in the rates of adverse events between vaccine recipients and controls (who receive normal saline solution instead of vaccine) in 15 different randomized, double-blind, placebo-controlled trials
